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believe this may be due to inexperience with this novel tech-
nology, although other influential factors could be that this 
study, in contrast to others, also included some patients with 
persistent AF and had a longer follow-up period. Unfortu-
nately, the study did not report how many pulmonary veins 
were in fact electrically reconnected with re-ablation pro-
cedures. This could provide more information on the long-
term success of isolation with the EAS. In addition, it would 
give insight into the incidence of AF recurrence despite 
successful isolation of the pulmonary veins. For example, 
one study [3] using this technique reported AF recurrence 
in 28 % of patients with persistent pulmonary vein isola-
tion after a median of 12-month follow-up. Moreover, three 
months after PVI, 14 % of ablated pulmonary veins were 
reconnected in 38 % of the patients, which entails that a 
large proportion of patients had at least one pulmonary vein 
electrically reconnected. We commend the authors for their 
contribution to optimising PVI outcomes and encourage 
them in their ongoing efforts to improve the PVI procedure 
with this refined technique. However, AF recurrences may 
also have aetiologies outside of our current understanding 
and perhaps these unknown pathological or physiological 
processes prevent further improvements in successful long-
term outcomes. For this, it is of utmost importance to learn 
more about the pathophysiology of AF.
The revolutionary findings of Haissaguerre et al. made 
it possible for a majority of patients with AF to be success-
fully treated with PVI. Unfortunately, another large pro-
portion of patients continue to have AF, and PVI seems to 
be insufficient. For this reason different ablation strategies 
were implemented, such as boxlines, roof, floor and isthmus 
lines, complex fractionated atrial electrogram ablation and 
ablation of ganglionated plexi. Nonetheless, AF still recurs 
and the pathophysiological background to support these 
additional strategies is controversial.
Treatment of atrial fibrillation (AF), the most prevalent 
tachyarrhythmia worldwide, remains a great challenge. 
About 15 years ago, when Haissaguerre et al. [1] first 
described episodes of AF triggered by focal activity origi-
nating from the pulmonary veins, the way was paved for 
ablative therapy of AF by pulmonary vein isolation (PVI). 
Despite a successful PVI, electric pulmonary vein reconnec-
tions still occur frequently requiring additional procedures. 
To this end new mapping, navigation, imaging and ablation 
techniques continue to be developed thereby facilitating and 
increasing success rates of PVI.
In this issue of the Netherlands Heart Journal, the results 
of the endoscopic laser balloon ablation system (EAS) 
for PVI are presented by Gal et al. [2] in 50 patients with 
mostly paroxysmal AF (82 %). The EAS provides an elegant 
manner for optimal circumferential contact and ablation 
lesions with one device applicable in pulmonary veins of 
various sizes. Furthermore, an endoscope within the device 
provides real-time visualisation of the ablation area. This 
resulted in isolation of 99.5 % of the pulmonary veins dur-
ing the ablation procedure. However, the long-term results 
were similar to other techniques and were somewhat lower 
compared with other studies using the EAS. The authors 
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To take new steps toward successful treatments for AF, 
we must further understand the underlying mechanism of 
AF, just as Haissaguerre et al. did almost two decades ago. 
In previous mapping studies, we demonstrated that longitu-
dinal dissociation in conduction and focal fibrillation waves 
are the key elements in persistence of AF [4, 5]. Figure 1 
shows an example of an epicardial high-resolution wave-
map (244 electrode, inter-electrode distance 2.5 mm) of 
the right atrial free wall obtained from a patient with long-
standing persistent AF demonstrating a complex pattern 
of activation. The wavemap shows individual fibrillation 
waves represented by colours according to their sequence 
of appearance. A previously described mapping algorithm 
was used to classify them intoperipheral waves (entering 
the mapping area from outside the electrode array), break-
through waves (appearing at the epicardial surface inside the 
mapping area) or discontinuous conduction waves (fibrilla-
tion waves starting with a delay of 13–40 ms from boundar-
ies of other waves). During this AF episode of only 140 ms, 
the mapping area (diameter: 4 cm) is activated by as many 
as 15 fibrillation waves, including 5 peripheral waves, 4 
epicardial breakthrough waves and 6 discontinuous waves. 
Hence, when patterns of activation during AF become too 
complex, the end stage of AF might have been reached and 
it is likely that PVI in these patients will be unsuccessful. 
We believe that by understanding the pathophysiology of 
AF we can come to new successful treatment strategies, 
which can be used when PVI just is not enough. Presum-
ably, this will entail a tailor-made treatment determined by 
different mechanisms underlying AF.
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Fig. 1 Wavemap constructed during longstanding persistent AF. Sites 
of epicardial breakthroughs are indicated by white asterisks; white ar-
rows indicate direction(s) of expansion of epicardial breakthrough or 
discontinuous fibrillation waves; black arrows indicate waves coming 
from outside the mapping area
 
